Milestone Scientific (MLSS) Stock Price, News & Analysis

Company Overview

Milestone Scientific Inc. is a medical device company that develops and commercializes computer-controlled drug-delivery systems. Its technology is designed to provide clinicians with precise control over the flow and pressure of injectable medications, with the goal of improving administration, patient comfort and clinical outcomes.

The company’s primary products serve the dental market. These include the CompuDent system and the STA Single Tooth Anesthesia System, which are intended to support computer-controlled local anesthesia delivery for a range of dental procedures. Milestone’s technology has also been developed for broader medical applications, including the controlled delivery of anesthetic and other injectable medications.

Founded in 1989, Milestone Scientific markets its products through direct sales and distribution relationships in the United States and international markets. The company is headquartered in Livingston, New Jersey, and focuses on expanding the use of its proprietary injection technology across dental and medical settings.

Key Stats

• Today's Range: $0.29 to $0.32
• 50-Day Range: $0.29 to $0.47
• 52-Week Range: $0.22 to $0.58
• Volume: 51,949 shs
• Average Volume: 720,709 shs
• Market Capitalization: $27.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.00
• Consensus Rating: Buy

Milestone Scientific Stock Analysis - MarketRank™

Milestone Scientific scored higher than 40% of companies evaluated by MarketBeat, and ranked 678th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Milestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Milestone Scientific has a consensus price target of $1.00, representing about 232.2% upside from its current price of $0.30.

Amount of Analyst Coverage

Milestone Scientific has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Milestone Scientific is -4.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Milestone Scientific is -4.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Milestone Scientific has a P/B Ratio of 2.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MLSS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Milestone Scientific does not currently pay a dividend.

Dividend Growth

Milestone Scientific does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.67

News Sentiment

Milestone Scientific has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Milestone Scientific this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Milestone Scientific insiders have not sold or bought any company stock.

Percentage Held by Insiders

9.22% of the stock of Milestone Scientific is held by insiders.

Percentage Held by Institutions

5.79% of the stock of Milestone Scientific is held by institutions.

Company Calendar

• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:MLSS
• CIK: 855683
• Web: www.milestonescientific.com
• Phone: (973) 535-2717
• Fax: 973-535-2829
• Employees: 15
• Year Founded: 1989

Price Target and Rating

• Average Price Target for Milestone Scientific: $1.00
• High Price Target: $1.00
• Low Price Target: $1.00
• Potential Upside/Downside: +243.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.93 million
• Net Margins: -52.01%
• Pretax Margin: -52.21%
• Return on Equity: -60.26%
• Return on Assets: -40.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.85
• Quick Ratio: 1.86

Sales & Book Value

• Annual Sales: $9.42 million
• Price / Sales: 2.80
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.11 per share
• Price / Book: 2.65

Miscellaneous

• Outstanding Shares: 90,644,000
• Free Float: 58,614,000
• Market Cap: $26.38 million
• Optionable: Optionable
• Beta: 1.14